Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 3Phase 1/2 3Phase NA 2Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Hepatocellular 12Refractory Solid Tumors 2Recurrence 2Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Neurologic Manifestations 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Liver Neoplasms 1Kidney Neoplasms 1HCC 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Radiotherapy 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 7Cyclophosphamide 7Busulfan 7Whole-Body Irradiation 6Melphalan 6Radiofrequency Ablation 5Mycophenolic Acid 5Filgrastim 5Antilymphocyte Serum 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Methotrexate 4Etoposide 4Drug Therapy 4Cisplatin 4fludarabine 3Radiosurgery 3Injections 3Hepatectomy 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2lenvatinib 2Vinblastine 2Videotape Recording 2Thiotepa 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recurrence × Sorafenib × Clear all
NCT02187081 2017-03-28

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

Southwest Hospital, China

Phase NA Unknown
380 enrolled

Recurrence

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown
20 enrolled

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡